DABUR · NSE
Dabur India Limited
₹395.25
+2.78% (+₹10.7)
Prev. close
₹384.55
Volume
24,55,500
Delivery %
68.2%
As of
18 Sept 2026
Price history
Analyst sentiment
Analysts lean bullish
3 analyst stances · last 90 days · one per analyst
Trackable
2 · 2 bull / 0 neutral / 0 bear
Long-Horizon
none in window
Commentary
1 · 1 bull / 0 neutral / 0 bear
Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded
Analyst opinions
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Bullish on Dabur India, recommending to buy at ₹383 with a target of ₹405 and a stop loss at ₹370.” | Vaishali ParekhPrabhudas Lilladher | Dabur India | PENDING | |
| “Consensus analyst estimates from Trendlyne project Dabur to deliver a potential upside of 31% over the next 12 months, w…” | ETMarkets AnalysisETMarkets.com | Dabur Ltd | PENDING | |
| “Consensus estimates from market analysts, compiled by Trendlyne, indicate a 'BUY' rating for Dabur, projecting a 26% ups…” | ETMarkets AnalysisETMarkets.com | Dabur | PENDING |
Market commentary · 1 · levels, conditionals, previews, macro & hedged views — context, not graded
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Nomura expects Dabur's India business to drive 9% YoY sales growth in Q1 FY27, with 5% volume growth and 4% pricing grow…” | Nomura AnalysisNomura Global Markets Research | Dabur | NOT GRADED |
Fundamentals
About Dabur India Limited
Dabur India Limited operates as a fast moving consumer goods company worldwide. It operates through Consumer Care Business, Foods Business, Retail Business, and Other segments. The company provides health supplements under the Dabur Chyawanprash, Dabur Honey, and Dabur Glucose brand name; digestive products under the Hajmola, Pudin Hara, Hingoli, Dabur Nature Care, and Sat Isabgol brands; cough and throat products under the Dabur Honitus brand name; baby care products under the Dabur Lal Tail; ayurvedic health juices; rejuvenators under the Dabur Shilajit brand name; Women's Health Tonics; and nutraceuticals under the Siens brand name, as well as Ayurvedic Ethicals. It also offers hair care products comprising hair oil and shampoo under the Dabur Amla, Vatika, and Dabur Almond brands; oral care products that includes toothpastes, gels, and toothpowders under the Dabur Red Paste, Dabur Babool, Meswak, Dabur Herb'l, and Dabur Lal Dant Manjan brands; skin care products, including rose water, moisturising creams and lotions, soaps, body wash, toners, facial bleaches, and depilatory creams under the Dabur Gulabari and Fem & OxyLife brand names; and home care products, such as air fresheners under Odonil name, mosquito repellents under the Odomos brand, and floor and toilet cleaner products under the Sanifresh brand name. In addition, the company provides beverages under the Réal and Réal Activ brand names; foods under the Dabur and Hommade brands; and spices under the Badshah brand, as well as edible oils and ghee which includes Dabur Cold Pressed Mustard, Sesame and Groundnut Oils, Virgin Coconut Oil, and Dabur 100% Cow Ghee. Further, it offers Guar gum, pharma, and other products. The company also operates specialized beauty retail stores that offer a range of cosmetics, fragrances, skin care, and personal care products, as well as beauty and fashion accessories under the NewU brand name. Dabur India Limited was founded in 1884 and is based in Ghaziabad, India.
Details
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Mr. Mohit Malhotra M.B.A.
Headquarters
Ghaziabad
Employees
4,768
Website
dabur.comExchange
View on NSE ↗Key stats
Market cap
₹68,217.52 Cr
P/E ratio (TTM)
34.6
Dividend yield
2.16%
EPS (TTM)
₹11.12
Beta (1Y · daily vs NIFTY 50)
0.96
Beta (5Y · monthly vs NIFTY 50)
0.91
Shares float
58.99 Cr
EPS · quarter ended Jun 2026
₹3.33
Upcoming earnings
29 Oct 2026
Financial Performance
01 · Financials
FY21 growth needs FY20 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹9,561.65 Cr | ₹10,888.68 Cr | ₹11,529.89 Cr | ₹12,404.01 Cr | ₹12,563.09 Cr | ₹13,192.57 Cr | |
| EBITDA | ₹2,327.97 Cr | ₹2,561.97 Cr | ₹2,609.51 Cr | ₹2,882.64 Cr | ₹2,866.44 Cr | ₹3,036.56 Cr |
| ₹1,693.30 Cr | ₹1,739.22 Cr | ₹1,707.15 Cr | ₹1,842.68 Cr | ₹1,767.63 Cr | ₹1,895.03 Cr | |
| Diluted EPS | ₹9.55 | ₹9.81 | ₹9.61 | ₹10.38 | ₹9.95 | ₹10.66 |
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹10,833.00 Cr | ₹12,284.00 Cr | ₹13,652.00 Cr | ₹15,116.00 Cr | ₹16,230.00 Cr | ₹17,480.00 Cr | |
| — | — | ₹1,173.79 Cr | ₹1,365.09 Cr | ₹950.08 Cr | ₹1,287.32 Cr | |
| Stockholders' equity | ₹7,664.00 Cr | ₹8,382.00 Cr | ₹8,973.00 Cr | ₹9,866.00 Cr | ₹10,800.00 Cr | ₹11,419.00 Cr |
Current assets, Inventory, Trade receivables, Cash & equivalents, Non-current assets, CWIP, Others, Total debt, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹2,115.00 Cr | ₹1,802.00 Cr | ₹1,488.00 Cr | ₹2,013.00 Cr | ₹1,987.00 Cr | ₹2,579.00 Cr | |
| Investing cash flow | ₹-1,405.78 Cr | ₹-1,275.45 Cr | ₹-586.54 Cr | ₹-971.74 Cr | ₹-449.11 Cr | ₹-1,285.22 Cr |
| ₹-613.00 Cr | ₹-490.00 Cr | ₹-1,035.00 Cr | ₹-1,161.00 Cr | ₹-1,405.00 Cr | ₹-1,236.00 Cr | |
| Capital expenditure | ₹-311.21 Cr | ₹-4.93 Cr | ₹-509.09 Cr | ₹-563.86 Cr | ₹-569.54 Cr | ₹-420.14 Cr |
| End cash position | ₹188.78 Cr | — | ₹97.57 Cr | ₹-21.18 Cr | ₹111.97 Cr | ₹175.68 Cr |
End cash position has filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 21 | Dec 21 | Mar 22 | Jun 22–Sep 22(2Q) | Dec 22–Mar 23(2Q) | Jun 23–Sep 23(2Q) | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25–Sep 25(2Q) | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 67.36% | 67.37% | 67.38% | 67.24% | 66.24% | 66.23% | 66.24% | 66.25% | 66.24% | 66.25% | 66.26% | 66.27% | 66.22% | 66.23% | 66.25% | 66.24% |
| Public | 32.64% | 32.63% | 32.62% | 32.76% | 33.76% | 33.77% | 33.76% | 33.75% | 33.76% | 33.75% | 33.74% | 33.73% | 33.78% | 33.77% | 33.75% | 33.76% |
| Employee trusts | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Consumer Defensive
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Hindustan Unilever Limited | ₹4.56 L Cr | ₹1,932 | 43.7 | 9.36 | 30.9% | 0.03 | +5.3% | -25.3% |
| ITC Limited | ₹3.34 L Cr | ₹262.3 | 16.8 | 4.60 | 28.5% | 0.03 | +4.8% | -36.3% |
| Nestle India Limited | ₹2.67 L Cr | ₹1,383.3 | 69.9 | 66.52 | 80.0% | 0.29 | +19.6% | +14.1% |
| Avenue Supermarts Limited | ₹2.42 L Cr | ₹3,749.9 | 79.4 | 9.89 | 12.1% | 0.10 | +16.0% | -21.2% |
| Varun Beverages Limited | ₹1.41 L Cr | ₹421.95 | 41.5 | 7.18 | 15.5% | 0.13 | +7.1% | -10.9% |
| Britannia Industries Limited | ₹1.20 L Cr | ₹4,982 | 45.7 | 23.58 | 49.6% | 0.27 | +7.5% | -18.3% |
| Marico Limited | ₹1.06 L Cr | ₹803.9 | 56.0 | 25.19 | 41.9% | 0.13 | +26.2% | +11.7% |
| TATA CONSUMER PRODUCTS LIMITED | ₹98,978.89 Cr | ₹1,013.7 | 60.4 | 4.54 | 7.1% | 0.13 | +15.2% | -10.8% |
| United Spirits Limited | ₹98,697.70 Cr | ₹1,371 | 58.5 | 11.02 | 20.5% | 0.05 | +7.8% | +3.3% |
| Godrej Consumer Products Limited | ₹89,334.52 Cr | ₹880 | 46.6 | 7.06 | 14.7% | 0.35 | +8.5% | -28.9% |
| Dabur India Limited | ₹67,765.15 Cr | ₹384.55 | 34.7 | 5.93 | 16.6% | 0.11 | +5.2% | -28.1% |
| Radico Khaitan Limited | ₹58,684.29 Cr | ₹4,535.4 | 83.1 | 17.70 | 18.2% | 0.24 | +24.8% | +50.7% |
Ranked by market cap within Consumer Defensive, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 30
Concall transcripts
Show all 11
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
43 indices
NSE weights are a free-float market-cap-share estimate, not NSE’s own published (and sometimes capped) index weight. BSE weights are BSE’s own published index weight, not an estimate. Indices without weight data are listed without one, in alphabetical order after the weighted ones.